Research Analysts Issue Forecasts for PIII FY2024 Earnings

P3 Health Partners Inc. (NASDAQ:PIII) – Stock analysts at William Blair cut their FY2024 earnings per share estimates for shares of P3 Health Partners in a research report issued to clients and investors on Wednesday, November 13th. William Blair analyst R. Daniels now expects that the company will post earnings of ($0.67) per share for the year, down from their previous estimate of ($0.23). The consensus estimate for P3 Health Partners’ current full-year earnings is ($0.67) per share. William Blair also issued estimates for P3 Health Partners’ Q4 2024 earnings at ($0.17) EPS, Q1 2025 earnings at ($0.11) EPS, Q2 2025 earnings at ($0.09) EPS, Q3 2025 earnings at ($0.11) EPS, Q4 2025 earnings at ($0.13) EPS and FY2025 earnings at ($0.42) EPS.

P3 Health Partners Price Performance

Shares of PIII stock opened at $0.21 on Monday. The stock’s fifty day moving average is $0.39 and its 200-day moving average is $0.50. The company has a debt-to-equity ratio of 1.11, a quick ratio of 0.69 and a current ratio of 0.53. P3 Health Partners has a 52 week low of $0.20 and a 52 week high of $1.78. The stock has a market capitalization of $75.94 million, a PE ratio of -0.25 and a beta of 1.15.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Geode Capital Management LLC lifted its stake in shares of P3 Health Partners by 115.2% during the third quarter. Geode Capital Management LLC now owns 1,029,259 shares of the company’s stock valued at $398,000 after acquiring an additional 550,925 shares during the period. Armistice Capital LLC bought a new stake in P3 Health Partners during the 2nd quarter worth about $3,557,000. Renaissance Technologies LLC lifted its position in P3 Health Partners by 188.1% during the 2nd quarter. Renaissance Technologies LLC now owns 111,800 shares of the company’s stock valued at $50,000 after purchasing an additional 73,000 shares during the period. Emfo LLC boosted its stake in shares of P3 Health Partners by 39.8% in the 2nd quarter. Emfo LLC now owns 1,427,689 shares of the company’s stock valued at $643,000 after purchasing an additional 406,418 shares during the last quarter. Finally, Sanders Morris Harris LLC grew its position in shares of P3 Health Partners by 16.3% during the 2nd quarter. Sanders Morris Harris LLC now owns 142,998 shares of the company’s stock worth $64,000 after buying an additional 20,000 shares during the period. 7.75% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, major shareholder Pacific Founders Ugp I. Chicago acquired 80,000 shares of the company’s stock in a transaction that occurred on Wednesday, September 4th. The stock was purchased at an average price of $0.49 per share, for a total transaction of $39,200.00. Following the transaction, the insider now directly owns 76,625,438 shares of the company’s stock, valued at approximately $37,546,464.62. This trade represents a 0.10 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders have purchased a total of 400,000 shares of company stock worth $205,600 in the last 90 days. Corporate insiders own 17.86% of the company’s stock.

P3 Health Partners Company Profile

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.